Citations (10)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Anders Løkke, Ole Hilberg, Peter Lange, Rikke Ibsen, Gunilla Telg, Georgios Stratelis & Jesper Lykkegaard. (2023) Exacerbations Predict Severe Cardiovascular Events in Patients with COPD and Stable Cardiovascular Disease–A Nationwide, Population-Based Cohort Study. International Journal of Chronic Obstructive Pulmonary Disease 18, pages 419-429.
Read now
Read now
Qing Song, Ling Lin, Aiyuan Zhou, Wei Cheng, Cong Liu, Yating Peng, Zijing Zhou, Yuqin Zeng, Dingding Deng, Dan Liu, Zhiping Yu, Yan Chen, Shan Cai & Ping Chen. (2023) The effects of different inhalation therapies on less symptomatic chronic obstructive pulmonary disease patients in a Chinese population: a real-world study. Annals of Medicine 55:1, pages 1317-1324.
Read now
Read now
Mario Cazzola, Paola Rogliani, Rossella Laitano, Luigino Calzetta & Maria Gabriella Matera. (2022) Beyond Dual Bronchodilation – Triple Therapy, When and Why. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 165-180.
Read now
Read now
Mario Cazzola, Josuel Ora, Luigino Calzetta, Paola Rogliani & Maria Gabriella Matera. (2022) Advances in inhaled corticosteroids for the treatment of chronic obstructive pulmonary disease: what is their value today?. Expert Opinion on Pharmacotherapy 23:8, pages 917-927.
Read now
Read now
Articles from other publishers (6)
Lowie E. G. W. Vanfleteren, Anne Lindberg, Caddie Zhou, Fredrik NybergCaroline Stridsman. (2023) Exacerbation Risk and Mortality in Global Initiative for Chronic Obstructive Lung Disease Group A and B Patients with and without Exacerbation History. American Journal of Respiratory and Critical Care Medicine 208:2, pages 163-175.
Crossref
Crossref
Janwillem Kocks, António Jorge Ferreira, Per Bakke, Onno C. P. van Schayck, Heikki Ekroos, Nikolaos Tzanakis, Stéphane Soulard, Monika Haaksma-Herczegh, Montserrat Mestres-Simon, Malena Águila-Fuentes & Didier Cataldo. (2023) Investigating the rationale for COPD maintenance therapy prescription across Europe, findings from a multi-country study. npj Primary Care Respiratory Medicine 33:1.
Crossref
Crossref
Ting Yang, Baiqiang Cai, Bin Cao, Jian Kang, Fuqiang Wen, Yahong Chen, Wenhua Jian & Chen Wang. (2023) Treatment patterns in patients with stable COPD in China: analysis of a prospective, 52-week, nationwide, observational cohort study (REAL). Therapeutic Advances in Respiratory Disease 17, pages 175346662311582.
Crossref
Crossref
Ting Yang, Baiqiang Cai, Bin Cao, Jian Kang, Fuqiang Wen, Yahong Chen, Wenhua Jian, Hongyan Shang & Chen Wang. (2022) Severity distribution and treatment of chronic obstructive pulmonary disease in China: baseline results of an observational study. Respiratory Research 23:1.
Crossref
Crossref
N. P. Knyazheskaya, E. Кh. Anaev, A. S. Belevskiy & M. A. Makarova. (2022) Double broncholytic combination of umeclidnium/ vilanterol in COPD therapy: issues of efficacy and safety. Meditsinskiy sovet = Medical Council 16:18, pages 49-54.
Crossref
Crossref
Sukanya Tongdee, Bundit Sawunyavisuth, Wattana Sukeepaisarnjaroen, Sittichai Khamsai & Kittisak Sawanyawisuth. (2021) Clinical factors predictive of appropriate treatment in COPD: a community hospital setting. Drug Target Insights 15, pages 21-25.
Crossref
Crossref